Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Nutex Health (NUTX) Free Cash Flow (2016 - 2026)

Nutex Health (NUTX) has disclosed Free Cash Flow for 17 consecutive years, with $74.3 million as the latest value for Q1 2026.

For Q1 2026, Free Cash Flow rose 46.0% year-over-year to $74.3 million; the TTM value through Mar 2026 reached $269.0 million, up 287.45%, while the annual FY2025 figure was $245.6 million, 1077.99% up from the prior year.
Free Cash Flow hit $74.3 million in Q1 2026 for Nutex Health, up from $69.0 million in the prior quarter.
Across five years, Free Cash Flow topped out at $99.2 million in Q3 2025 and bottomed at -$13.2 million in Q3 2022.
Average Free Cash Flow over 5 years is $21.7 million, with a median of $9.6 million recorded in 2022.
Year-over-year, Free Cash Flow crashed 163.54% in 2022 and then surged 20328.74% in 2025.
Nutex Health's Free Cash Flow stood at $12.4 million in 2022, then tumbled by 107.67% to -$950183.0 in 2023, then skyrocketed by 64.11% to -$341000.0 in 2024, then soared by 20328.74% to $69.0 million in 2025, then grew by 7.74% to $74.3 million in 2026.
According to Business Quant data, Free Cash Flow over the past three periods came in at $74.3 million, $69.0 million, and $99.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.